• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma.微小RNA-34a过表达通过调控沉默信息调节因子1抑制肝癌细胞的迁移和侵袭。
Oncol Lett. 2017 Dec;14(6):6950-6954. doi: 10.3892/ol.2017.7090. Epub 2017 Sep 28.
2
MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.微小 RNA-34a 通过调控 CD44 抑制食管鳞癌细胞的侵袭和转移。
Mol Cell Biochem. 2018 Jun;443(1-2):139-149. doi: 10.1007/s11010-017-3218-3. Epub 2017 Nov 1.
3
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.微小 RNA-34a:p53 突变型神经胶质瘤细胞系 U251 中的一种新型肿瘤抑制因子。
Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.
4
Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.抑癌 microRNA-34a 通过靶向 MMP-2/MMP-9/FNDC3B 抑制食管鳞癌细胞迁移和侵袭。
Int J Oncol. 2017 Jul;51(1):378-388. doi: 10.3892/ijo.2017.4015. Epub 2017 May 19.
5
MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.微小RNA-34a通过调控人SW480细胞中的沉默信息调节因子1/p53信号通路来抑制细胞迁移和侵袭。
Mol Med Rep. 2015 May;11(5):3301-7. doi: 10.3892/mmr.2015.3182. Epub 2015 Jan 12.
6
MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating , and Caspase-3.微小RNA-34a通过调节 以及半胱天冬酶-3来抑制肝细胞癌的侵袭性。 (注:原文中“modulating ”后面似乎缺失了具体内容)
Cancer Manag Res. 2019 Apr 10;11:2963-2976. doi: 10.2147/CMAR.S202664. eCollection 2019.
7
Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.EZH2、Bmi-1和miR-203在肝癌细胞系Hep3B细胞增殖和侵袭中的潜在作用
World J Gastroenterol. 2015 Dec 21;21(47):13268-76. doi: 10.3748/wjg.v21.i47.13268.
8
MicroRNA-212-3p inhibits paclitaxel resistance through regulating epithelial-mesenchymal transition, migration and invasion by targeting ZEB2 in human hepatocellular carcinoma.微小RNA-212-3p通过靶向ZEB2调控人肝癌上皮-间质转化、迁移和侵袭来抑制紫杉醇耐药。
Oncol Lett. 2020 Oct;20(4):23. doi: 10.3892/ol.2020.11884. Epub 2020 Jul 16.
9
Sevoflurane inhibits migration and invasion of colorectal cancer cells by regulating microRNA-34a/ADAM10 axis.七氟醚通过调控 microRNA-34a/ADAM10 轴抑制结直肠癌细胞的迁移和侵袭。
Neoplasma. 2019 Jul 12;66(6):887-895. doi: 10.4149/neo_2018_181213N962. Print 2019 Nov.
10
MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.微小RNA-34a直接靶向高迁移率族蛋白盒1,并抑制皮肤鳞状细胞癌中的癌细胞增殖、迁移和侵袭。
Exp Ther Med. 2017 Dec;14(6):5611-5618. doi: 10.3892/etm.2017.5245. Epub 2017 Oct 2.

引用本文的文献

1
Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets.非编码 RNA 作为胶质母细胞瘤 Notch 信号通路的关键调控因子:诊断、预后和治疗靶点。
CNS Neurol Disord Drug Targets. 2024;23(10):1203-1216. doi: 10.2174/0118715273277458231213063147.
2
Echinocystic acid induces the apoptosis, and inhibits the migration and invasion of non-small cell lung cancer cells.棘叶酸诱导非小细胞肺癌细胞凋亡,并抑制其迁移和侵袭。
Med Oncol. 2023 May 19;40(6):182. doi: 10.1007/s12032-023-02029-2.
3
The sirtuin family in health and disease.长寿蛋白家族与健康和疾病。
Signal Transduct Target Ther. 2022 Dec 29;7(1):402. doi: 10.1038/s41392-022-01257-8.
4
Differential expression of cancer associated plasma miRNAs in the ordnance factory workers, exposed to 2,4,6-Trinitrotoluene.暴露于2,4,6-三硝基甲苯的兵工厂工人中癌症相关血浆微小RNA的差异表达
Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):547-552. doi: 10.12669/pjms.38.3.4928.
5
MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing.微小 RNA-34a-5p 通过沉默基质金属蛋白酶-2 来调节膀胱癌细胞的运动性,从而发挥肿瘤抑制作用。
Oncol Rep. 2021 Mar;45(3):911-920. doi: 10.3892/or.2020.7910. Epub 2020 Dec 24.
6
C-Peptide Inhibits Decidualization in Human Endometrial Stromal Cells via GSK3β-PP1.C肽通过GSK3β-PP1抑制人子宫内膜基质细胞蜕膜化。
Front Cell Dev Biol. 2020 Nov 30;8:609551. doi: 10.3389/fcell.2020.609551. eCollection 2020.
7
The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.Sirtuins 和 microRNAs 在肝细胞癌治疗中的可能作用。
Cell Cycle. 2020 Dec;19(23):3209-3221. doi: 10.1080/15384101.2020.1843813. Epub 2020 Nov 9.
8
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma.SIRT1在肝细胞癌的发生发展及治疗中的作用
Front Nutr. 2019 Sep 25;6:148. doi: 10.3389/fnut.2019.00148. eCollection 2019.
9
SIRT1 inhibits hepatocellular carcinoma metastasis by promoting M1 macrophage polarization via NF-κB pathway.沉默信息调节因子1通过核因子κB途径促进M1型巨噬细胞极化来抑制肝细胞癌转移。
Onco Targets Ther. 2019 Apr 4;12:2519-2529. doi: 10.2147/OTT.S195234. eCollection 2019.
10
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.复制研究:miR-34a 通过直接抑制 CD44 抑制前列腺癌干细胞和转移。
Elife. 2019 Mar 12;8:e43511. doi: 10.7554/eLife.43511.

本文引用的文献

1
Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.SIRT1表达在分子亚型乳腺癌肿瘤侵袭和转移中的独特作用
Hum Pathol. 2015 Jul;46(7):1027-35. doi: 10.1016/j.humpath.2015.03.015. Epub 2015 Apr 15.
2
Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival.泛素化的沉默信息调节因子1(SIRT1)的功能在DNA损伤诱导的细胞死亡和存活过程中受到调控。
J Biol Chem. 2015 Apr 3;290(14):8904-12. doi: 10.1074/jbc.M114.612796. Epub 2015 Feb 10.
3
Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.SIRT1的过表达通过上皮-间质转化促进肝细胞癌转移。
BMC Cancer. 2014 Dec 18;14:978. doi: 10.1186/1471-2407-14-978.
4
miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.微小RNA-224通过靶向人肝细胞癌中的同源盒D10基因促进细胞迁移和侵袭。
J Gastroenterol Hepatol. 2014 Apr;29(4):835-42. doi: 10.1111/jgh.12429.
5
Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.一项针对 4741 例非 B 非 C 型肝细胞癌患者的全国性研究,特别关注治疗效果。
Ann Surg. 2014 Feb;259(2):336-45. doi: 10.1097/SLA.0b013e31829291e9.
6
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.TGF-β-miR-34a-CCL22 信号诱导 Treg 细胞募集促进 HBV 阳性肝细胞癌的静脉转移。
Cancer Cell. 2012 Sep 11;22(3):291-303. doi: 10.1016/j.ccr.2012.07.023.
7
MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.微小RNA:加工、成熟、靶标识别及调控功能
Mol Cell Pharmacol. 2011;3(3):83-92.
8
Identification of four isoforms of aldolase B down-regulated in hepatocellular carcinoma tissues by means of two-dimensional Western blotting.利用二维 Western 印迹技术鉴定肝癌组织中下调的醛缩酶 B 的四种同工型。
In Vivo. 2011 Nov-Dec;25(6):881-6.
9
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
10
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.微小 RNA miR-34a 通过直接抑制 CD44 抑制前列腺癌干细胞和转移。
Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16.

微小RNA-34a过表达通过调控沉默信息调节因子1抑制肝癌细胞的迁移和侵袭。

microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma.

作者信息

Zhou Jianhui, Zhou Wenying, Kong Fangen, Xiao Xiaoyu, Kuang Haoyu, Zhu Yingxian

机构信息

Department of Clinical Laboratory, Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, P.R. China.

Department of Central Laboratory, Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, P.R. China.

出版信息

Oncol Lett. 2017 Dec;14(6):6950-6954. doi: 10.3892/ol.2017.7090. Epub 2017 Sep 28.

DOI:10.3892/ol.2017.7090
PMID:29344126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5754896/
Abstract

Hepatocellular carcinoma (HCC) remains one of the most common types of malignancy with high mortality and morbidity rates. Previous studies have suggested that microRNAs (miRs) serve pivotal functions in various types of tumor. The aim of the present study was to assess the association between miR-34a expression and HCC cell migration and invasion, and the potential underlying mechanisms. The miR-34a overexpression vector or scramble control was transfected into human Hep3B and Huh7 cell lines. Transwell assays, and Matrigel and wound healing assays were used to detect the effects of miR-34a expression on HCC cell invasion and migration, respectively. The expression of miR-34a and the mRNA expression of other associated proteins were detected using quantitative reverse transcription polymerase chain reaction, and protein levels were measured using western blot analysis. Compared with the control, miR-34a expression was significantly downregulated in Hep3B and Huh7 cells, but this was reversed by the transfection with exogenous miR-34a (P<0.01). The number of migrated or invaded cells was significantly reduced by the overexpression of miR-34a in Hep3B or Huh7 cells (P<0.01). The expression of sirtuin 1 was upregulated, while the level of acetylate-p53 was downregulated by overexpression of miR-34a. Taken together, the results of the present study suggested that the overexpression of miR-34a may have suppressed HCC metastasis via inhibited cell migration and invasion.

摘要

肝细胞癌(HCC)仍然是最常见的恶性肿瘤类型之一,死亡率和发病率都很高。先前的研究表明,微小RNA(miR)在各种类型的肿瘤中发挥着关键作用。本研究的目的是评估miR-34a表达与HCC细胞迁移和侵袭之间的关联以及潜在的机制。将miR-34a过表达载体或乱序对照转染到人Hep3B和Huh7细胞系中。分别使用Transwell实验、基质胶实验和伤口愈合实验检测miR-34a表达对HCC细胞侵袭和迁移的影响。使用定量逆转录聚合酶链反应检测miR-34a的表达以及其他相关蛋白的mRNA表达,并使用蛋白质印迹分析测量蛋白质水平。与对照组相比,Hep3B和Huh7细胞中miR-34a表达显著下调,但通过转染外源性miR-34a可使其逆转(P<0.01)。miR-34a在Hep3B或Huh7细胞中的过表达显著减少了迁移或侵袭细胞的数量(P<0.01)。miR-34a过表达上调了沉默调节蛋白1的表达,同时下调了乙酰化-p53的水平。综上所述,本研究结果表明,miR-34a的过表达可能通过抑制细胞迁移和侵袭来抑制HCC转移。